Successful closing of B series funding

 

Theobald Associates is pleased to announce the successful closing of a Series B Fundraising for its client, the UK-based antiviral drug discovery Company Reviral Limited. The transaction raised USD$55 million for the BioTech and will enable it to progress its lead drug candidate. The funding came from a syndicate of international institutional investors. Further details can be found HERE.